SCHEMBL6980956

SCHEMBL6980956

Cc1c(S(=O)(=O)Nc2ccc(O)c(N3CCN(C)CC3)c2)sc2ccc(Cl)cc12

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 13/20 0.77
HTR1A P08908 9/20 0.77
HTR1D P28221 9/20 0.77
HTR1B P28222 9/20 0.77
HTR7 P34969 6/20 0.77
HTR2A P28223 6/20 0.77
HTR2C P28335 6/20 0.77
DRD2 P14416 6/20 0.77
ADRA1B P35368 6/20 0.77
DRD3 P35462 6/20 0.77
HTR4 Q13639 5/20 0.77
HTR2B P41595 5/20 0.77
HTR1E P28566 3/20 0.77
HTR1F P30939 3/20 0.77
PFKFB3 Q16875 3/20 0.64
DRD1 P21728 1/20 0.63
DRD4 P21917 1/20 0.63
PFKFB4 Q16877 2/20 0.62
CYP1A2 P05177 1/20 0.62
ADRB1 P08588 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6981823 0.90 HTR6 (0.80) HTR6HTR1AHTR1DHTR1BHTR7
SCHEMBL6972216 0.90 HTR6 (0.80) HTR6HTR1AHTR1DHTR1BHTR7
SCHEMBL29496144 0.87 HTR6 (1.00) HTR6HTR1AHTR1DHTR1BHTR7
SCHEMBL1136525 0.87 HTR6 (1.00) HTR6HTR1AHTR1DHTR1BHTR7
SCHEMBL6975269 0.85 HTR6 (0.86) HTR6HTR1AHTR1DHTR1BHTR7
SCHEMBL6979823 0.85 HTR6 (0.82) HTR6HTR1AHTR1DHTR1BHTR7
SCHEMBL6981982 0.85 HTR6 (0.82) HTR6HTR1AHTR1DHTR1BHTR7
SCHEMBL7199492 0.81 HTR6 (0.76) HTR6HTR1AHTR1DHTR1BHTR7
SCHEMBL7200160 0.81 HTR6 (1.00) HTR6HTR1AHTR1DHTR1BHTR7
SCHEMBL10239970 0.79 HTR6 (0.63) HTR6HTR1AHTR1DHTR1BHTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0946539-B1 SULPHONAMIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND THEIR USE AS MEDICAMENTS SMITHKLINE BEECHAM PLC (GB) 2003-08-13 EP claimed
US-6599904-B2 5-HT6 receptor antagonists are believed to be of potential use in the treatment of certain CNS disorders; cognitive memory enhancement SMITHKLINE BEECHAM P.L.C. (GB) 2003-07-29 US disclosed